Nobukazu Miyamoto
Overview
Explore the profile of Nobukazu Miyamoto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
98
Citations
1540
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
McCabe J, Walsh C, Gorey S, Arnold M, DeMarchis G, Harris K, et al.
Stroke
. 2024 Oct;
55(12):2825-2834.
PMID: 39479747
Background: Inflammation promotes atherogenesis. Randomized controlled trials of anti-inflammatory therapies for prevention after stroke have not yet demonstrated clear benefit. IL-6 (interleukin-6) and hsCRP (high-sensitivity C-reactive protein) are independently associated...
2.
Niiyama S, Ueno Y, Kurita N, Nakajima S, Kijima C, Hira K, et al.
J Stroke Cerebrovasc Dis
. 2024 Oct;
33(12):108048.
PMID: 39476743
Purpose: A high-risk patent foramen ovale (PFO) could be the cause of cryptogenic stroke, and an atrial septal aneurysm (ASA) increases the risk of stroke recurrence in cryptogenic stroke patients...
3.
Kanazawa K, Miyamoto N, Hira K, Kijima C, Hattori N
BMC Neurol
. 2024 Aug;
24(1):298.
PMID: 39198817
Background And Aims: Compared to small vessel occlusion (SVO) patients, branch atheromatous disease (BAD) patients are more likely to develop early neurological deterioration (END). Stroke patients with END have a...
4.
McCabe J, Walsh C, Gorey S, Harris K, Hervella P, Iglesias-Rey R, et al.
Eur Stroke J
. 2024 Apr;
9(3):704-713.
PMID: 38600679
Introduction: Inflammation is an emerging target for secondary prevention after stroke and randomised trials of anti-inflammatory therapies are ongoing. Fibrinogen, a putative pro-inflammatory marker, is associated with first stroke, but...
5.
Shimada Y, Todo K, Doijiri R, Yamazaki H, Sonoda K, Koge J, et al.
Stroke
. 2024 Mar;
55(4):946-953.
PMID: 38436115
Background: Covert atrial fibrillation (AF) is a major cause of cryptogenic stroke. This study investigated whether a dose-dependent relationship exists between the frequency of premature atrial contractions (PACs) and AF...
6.
Todo K, Okazaki S, Doijiri R, Yamazaki H, Sonoda K, Koge J, et al.
J Am Heart Assoc
. 2024 Jan;
13(3):e031508.
PMID: 38240210
Background: Atrial fibrillation (AF) is known to be a strong risk factor for stroke. However, the risk of stroke recurrence in patients with cryptogenic stroke with AF detected after stroke...
7.
McCabe J, Walsh C, Gorey S, Harris K, Hervella P, Iglesias-Rey R, et al.
Neurology
. 2024 Jan;
102(2):e208016.
PMID: 38165328
Background And Objectives: Anti-inflammatory therapies reduce major adverse cardiovascular events (MACE) in coronary artery disease but remain unproven after stroke. Establishing the subtype-specific association between inflammatory markers and recurrence risk...
8.
Miyamoto N, Ueno Y, Yamashiro K, Hira K, Kijima C, Kitora N, et al.
Front Neurol
. 2023 Dec;
14:1295642.
PMID: 38156087
Background And Aims: It is important to diagnose cerebral infarction at an early stage and select an appropriate treatment method. The number of stroke-trained physicians is unevenly distributed; thus, a...
9.
Kijima C, Inaba T, Hira K, Miyamoto N, Yamashiro K, Urabe T, et al.
Mol Neurobiol
. 2023 Sep;
61(2):1022.
PMID: 37728851
No abstract available.
10.
Kijima C, Inaba T, Hira K, Miyamoto N, Yamashiro K, Urabe T, et al.
Mol Neurobiol
. 2023 Sep;
61(2):1002-1021.
PMID: 37676390
There are no effective treatments for post-stroke glial scar formation, which inhibits axonal outgrowth and functional recovery after stroke. We investigated whether astrocytic extracellular vesicles (AEVs) regulated by microglia modulate...